GGrantIndex
Sort

53,477 grants matching addiction

Novel Medications for Cannabis Dependence

$580,803
Alexandros Makriyannis · Northeastern University · R01 · FY2009 · DA

Understanding Emerging Patterns of Non-Daily Smoking: Field and Lab Assessments

$580,797
Saul Shiffman · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · DA

Amygdala Output Circuitry in Reward Encoding, Expectation, and Decision Making

$580,754
Kate Wassum · University Of California Los Angeles · R01 · FY2025 · DA

Prescription opioid use, misuse, disorders and HIV outcomes

$580,743
Joanna L. Starrels · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · DA

Transition to Long-Term Opioid Use Among Older Adults with Chronic Pain

$580,697
Michael R Von Korff · Kaiser Foundation Health Plan Of Washington · R01 · FY2012 · AG

Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) Experiment

$580,659
Michael L Dennis · Chestnut Health Systems, Inc. · R01 · FY2019 · DA

Beyond the classic VTA: extended amygdala influence on DA subcircuits in primate

$580,602
Julie L Fudge · University Of Rochester · R01 · FY2018 · MH

Efficacy of a Virtual Reality Neuroscience-based Therapy for Chronic Low Back Pain

$580,584
Amanda Way · Cognifisense, Inc. · R44 · FY2025 · NR

Adoption of Innovations in Private A & D Treatment Centers

$580,582
Paul M Roman · University Of Georgia · R37 · FY2014 · DA

DAT18-08 Geographic variation in Opioid Addiction Treatment (GATE) study: Multi-Level Factors Influencing MAT Use, Other Treatment, & Adverse Outcomes among Re-entering Rural and Urban Prisoners

$580,566
Carrie Beth Oser · University Of Kentucky · R01 · FY2022 · DA

Administrative Core

$580,512
Josiah D Rich · Rhode Island Hospital · P20 · FY2020 · GM

Novel Determinants and Measures of Smokeless Tobacco Use

$580,454
Dorothy K Hatsukami · University Of Minnesota · R01 · FY2009 · CA

Novel and Atypical Dopamine Uptake Inhibitors

$580,407
Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2019 · DA

Substance Dependent Adolescents: Imaging Risk-Taking

$580,391
Thomas J Crowley · University Of Colorado Denver · R01 · FY2008 · DA

RCMI@Morgan: Center for Urban Health Disparities Research and Innovation

$580,363
James M Wachira · Morgan State University · U54 · FY2020 · MD

Cortical and Subcortical Mechanisms of Human Cognitive Control

$580,289
Susan M Courtney-Faruqee · Johns Hopkins University · R01 · FY2014 · DA

Teenage Stimulant Use: Neurally Plausible Spontaneous and Protective Processes

$580,216
Alan W Stacy · Claremont Graduate University · R01 · FY2012 · DA

Inflammasome and unstable atherosclerotic plaques

$580,208
Ming-Hui Zou · Georgia State University · R01 · FY2022 · HL

Integrated Treatment for Veterans with Co-Occurring Chronic Pain and Opioid Use Disorder

$580,183
Katie A Witkiewitz · University Of New Mexico · UH3 · FY2021 · DA

Treatment Study Using Depot Naltrexone(1/6)Philadelphia Coord/Data Mgmt Site

$580,179
Charles P O'Brien · University Of Pennsylvania · R01 · FY2010 · DA

Modulation of GABAB receptor signaling

$580,168
Stephen J Moss · Tufts University Boston · R01 · FY2010 · NS

1 of 2: Real-time fMRI Pattern Training for Treatment of Craving and Addiction

$580,117
Anna Rose Childress · University Of Pennsylvania · R33 · FY2011 · DA

Identification of small molecules that regulate endogenous opioid signaling by inhibiting angiotensin converting enzyme

$580,098
Swati S More · University Of Minnesota · R01 · FY2023 · DA

Striatal mechanisms for e-cigarette reinforcement by flavorants

$580,069
Mariella De Biasi · University Of Pennsylvania · R01 · FY2020 · DA

Psychology Training in Alcohol Research (PTAR)

$579,984
Mary E Larimer · University Of Washington · T32 · FY2025 · AA